Functional significance of differential eNOS translocation.

PubWeight™: 1.94‹?› | Rank: Top 2%

🔗 View Article (PMC 1629085)

Published in Am J Physiol Heart Circ Physiol on May 05, 2006

Authors

Fabiola A Sánchez1, Nirav B Savalia, Ricardo G Durán, Brajesh K Lal, Mauricio P Boric, Walter N Durán

Author Affiliations

1: Program in Vascular Biology, Department of Pharmacology, UMDNJ-New Jersey Medical School, 185 South Orange Ave., MSB H-638, PO Box 1709, Newark, NJ 07101-1709, USA. sanchefa@umdnj.edu

Articles citing this

Life history of eNOS: partners and pathways. Cardiovasc Res (2007) 2.53

The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res (2010) 1.43

Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med (2011) 1.17

Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability. Proc Natl Acad Sci U S A (2009) 1.14

IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs. Proc Natl Acad Sci U S A (2007) 1.07

Vascular permeability and drug delivery in cancers. Front Oncol (2013) 0.99

Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules. Am J Physiol Heart Circ Physiol (2008) 0.97

S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability. Circ Res (2012) 0.95

Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability. J Biol Chem (2011) 0.94

New insights into eNOS signaling in microvascular permeability. Am J Physiol Heart Circ Physiol (2006) 0.89

Endothelial caveolar hub regulation of adenosine triphosphate-induced endothelial nitric oxide synthase subcellular partitioning and domain-specific phosphorylation. Hypertension (2012) 0.89

Nitric oxide, S-nitrosation, and endothelial permeability. IUBMB Life (2013) 0.87

Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase. Clin Exp Pharmacol Physiol (2013) 0.86

Coordinated endothelial nitric oxide synthase activation by translocation and phosphorylation determines flow-induced nitric oxide production in resistance vessels. J Vasc Res (2013) 0.86

Peptide-stimulation enhances compartmentalization and the catalytic activity of lung endothelial NOS. Cell Physiol Biochem (2009) 0.85

Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxid Med Cell Longev (2016) 0.84

Membrane raft redox signalosomes in endothelial cells. Free Radic Res (2010) 0.81

Nitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review). Mol Med Rep (2014) 0.81

S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability. Am J Physiol Heart Circ Physiol (2016) 0.81

Independent regulation of periarteriolar and perivenular nitric oxide mechanisms in the in vivo hamster cheek pouch microvasculature. Microcirculation (2009) 0.80

S-nitrosation of proteins: An emergent regulatory mechanism in microvascular permeability and vascular function. Tissue Barriers (2013) 0.80

Endothelial nitric oxide synthase in the microcirculation. Cell Mol Life Sci (2015) 0.79

A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation. Am J Physiol Heart Circ Physiol (2008) 0.78

GABAB receptors expressed in human aortic endothelial cells mediate intracellular calcium concentration regulation and endothelial nitric oxide synthase translocation. Biomed Res Int (2014) 0.77

Palmitoyl acyltransferase DHHC21 mediates endothelial dysfunction in systemic inflammatory response syndrome. Nat Commun (2016) 0.77

Rnd3 as a Novel Target to Ameliorate Microvascular Leakage. J Am Heart Assoc (2016) 0.76

Elevated uptake of plasma macromolecules by regions of arterial wall predisposed to plaque instability in a mouse model. PLoS One (2014) 0.76

Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia. Redox Biol (2017) 0.75

S-nitrosylation of VASP at Cysteine 64 Mediates Inflammation Stimulated Increase in Microvascular Permeability. Am J Physiol Heart Circ Physiol (2017) 0.75

Articles cited by this

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02

Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem (1996) 4.50

Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A (1996) 3.83

Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem (1997) 3.80

Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem (1996) 3.75

Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem (1997) 2.76

Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem (2001) 2.56

Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res (1996) 2.43

Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem (2001) 2.42

The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem (1995) 2.20

The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. J Cell Biol (1997) 1.89

Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem (1999) 1.87

VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun (1999) 1.53

Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J Biol Chem (2001) 1.51

VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol (2002) 1.49

Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion. Circ Res (2002) 1.46

VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvasc Res (2001) 1.45

Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol (1993) 1.41

Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1999) 1.35

Receptor-regulated translocation of endothelial nitric-oxide synthase. J Biol Chem (1998) 1.31

Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae. J Biol Chem (2004) 1.20

Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun (1996) 1.19

Trafficking of endothelial nitric-oxide synthase in living cells. Quantitative evidence supporting the role of palmitoylation as a kinetic trapping mechanism limiting membrane diffusion. J Biol Chem (1999) 1.17

Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. Microvasc Res (1995) 1.16

Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation. Circ Res (1988) 1.06

Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo. Microvasc Res (2000) 1.02

ACh-induced endothelial NO synthase translocation, NO release and vasodilatation in the hamster microcirculation in vivo. J Physiol (2002) 1.01

Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway. Nitric Oxide (2004) 0.95

Acute microcirculatory effects of platelet-activating factor. J Lipid Mediat (1990) 0.94

A novel anti-inflammatory peptide inhibits endothelial cell cytoskeletal rearrangement, nitric oxide synthase translocation, and paracellular permeability increases. J Cell Physiol (1997) 0.94

Resistance and exchange microvessels are modulated by different PAF receptors. Am J Physiol (1991) 0.90

Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C. Am J Physiol (1994) 0.89

Role of nitric oxide in leukotriene C4-induced increases in microvascular transport. Am J Physiol (1993) 0.84

Articles by these authors

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis (2010) 2.35

Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction. Am J Physiol Heart Circ Physiol (2005) 1.94

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg (2011) 1.92

Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial. Stroke (2011) 1.69

Carotid artery stenting: analysis of data for 105 patients at high risk. J Vasc Surg (2003) 1.53

VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol (2002) 1.49

Carotid artery closure for endarterectomy does not influence results of angioplasty-stenting for restenosis. J Vasc Surg (2002) 1.38

Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo. J Physiol (2006) 1.36

Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Circ Res (2008) 1.34

Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg (2008) 1.33

Carotid artery stenting: is there a need to revise ultrasound velocity criteria? J Vasc Surg (2004) 1.27

Acupuncture reduces experimental renovascular hypertension through mechanisms involving nitric oxide synthases. Microcirculation (2006) 1.26

Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. Am J Physiol Heart Circ Physiol (2004) 1.20

Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability. Proc Natl Acad Sci U S A (2009) 1.14

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: executive summary. J Vasc Surg (2011) 1.13

Pixel distribution analysis of B-mode ultrasound scan images predicts histologic features of atherosclerotic carotid plaques. J Vasc Surg (2002) 1.10

Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol (2006) 1.10

p42/44MAPK regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvasc Res (2002) 1.03

Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Circulation (2012) 1.03

Differential role of S-nitrosylation and the NO-cGMP-PKG pathway in cardiac contractility. Nitric Oxide (2007) 1.02

ACh-induced endothelial NO synthase translocation, NO release and vasodilatation in the hamster microcirculation in vivo. J Physiol (2002) 1.01

Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules. Am J Physiol Heart Circ Physiol (2008) 0.97

Functional role of gap junctions in cytokine-induced leukocyte adhesion to endothelium in vivo. Am J Physiol Heart Circ Physiol (2008) 0.97

Lymphorrhea responds to negative pressure wound therapy. J Vasc Surg (2007) 0.97

S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability. Circ Res (2012) 0.95

Does severe venous insufficiency have a different etiology in the morbidly obese? Is it venous? J Vasc Surg (2003) 0.95

Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability. J Biol Chem (2011) 0.94

Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). J Vasc Surg (2012) 0.91

Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model. Am J Physiol Heart Circ Physiol (2012) 0.89

The double-edge sword of TNF-alpha in ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2008) 0.86

Coordinated endothelial nitric oxide synthase activation by translocation and phosphorylation determines flow-induced nitric oxide production in resistance vessels. J Vasc Res (2013) 0.86

Altered proliferative responses of dermal fibroblasts to TGF-beta1 may contribute to chronic venous stasis ulcer. J Vasc Surg (2003) 0.86

Methicillin-resistant Staphylococcus aureus infection does not adversely affect clinical outcome of lower extremity amputations. Ann Vasc Surg (2003) 0.84

Technical challenges in a program of carotid artery stenting. J Vasc Surg (2004) 0.83

Noninvasive identification of the unstable carotid plaque. Ann Vasc Surg (2006) 0.81

Independent regulation of periarteriolar and perivenular nitric oxide mechanisms in the in vivo hamster cheek pouch microvasculature. Microcirculation (2009) 0.80

Durability and cumulative functional patency of transposed and nontransposed arteriovenous fistulas. J Vasc Surg (2003) 0.80

Histamine reduces gap junctional communication of human tonsil high endothelial cells in culture. Microvasc Res (2004) 0.80

High glucose increases B1-kinin receptor expression and signaling in endothelial cells. Biochem Biophys Res Commun (2006) 0.80

Trauma-hemorrhagic shock induces a CD36-dependent RBC endothelial-adhesive phenotype. Crit Care Med (2014) 0.79

Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo. Microcirculation (2010) 0.79

Stroke: advances in medical therapy and acute stroke intervention. Curr Cardiol Rep (2015) 0.76

Investigation of cerebral hemodynamics and collateralization in asymptomatic carotid stenoses. Conf Proc IEEE Eng Med Biol Soc (2012) 0.76

Mitogen-activated protein kinases regulate platelet-activating factor-induced hyperpermeability. Microcirculation (2005) 0.76

Restenosis after carotid endarterectomy and stenting--authors' reply. Lancet Neurol (2012) 0.76

Changes in Function After a 6-Month Walking Intervention in Patients With Intermittent Claudication Who Are Obese or Nonobese. J Geriatr Phys Ther (2016) 0.75

Commentary. Optimal carotid duplex velocity criteria for defining the severity of carotid in-stent restenosis. Perspect Vasc Surg Endovasc Ther (2009) 0.75

Oncoplastic Split Reduction with Intraoperative Radiation Therapy. Ann Surg Oncol (2015) 0.75

Clinical viability of carotid plaque strain estimation using B-mode ultrasound image sequences. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75

When is a more proximal amputation needed? Clin Podiatr Med Surg (2005) 0.75

Causes of severe chronic venous insufficiency. Semin Vasc Surg (2005) 0.75

Creation of arteriovenous fistulas upregulates venous eNOS. Vasc Endovascular Surg (2007) 0.75

Outcome of carotid artery stenting for primary versus restenotic lesions. Ann Vasc Surg (2008) 0.75